46.000
−1,50%
2026-10-19
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +32.0% | +112.3% | 3 / 3 | +44.7% | -0.32 pp | -3.38 pp | +33.2% | 0.04 | 5.53 | 132 | +44,7% | 46,4 | +32,0% | 5.53 | 11.14 | −50,4% |
| Pts | 8 | 12 | 12 | 12 | 4 | 0 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 46.000 (close price on 2026-10-19)EPS (TTM): 8.322
Financial charts
1.Revenue & growth
VND bn132Q2/26
1.Revenue & growth
VND bn132Q2/26
2.Profit & growth
VND bn51,2Q2/26
3.Profit mix (Penman)
VND bn233Q2/26
4.Margins & cost structure
%51.3%Q2/26
5.Returns & cash cycle
% · days70.6%Q2/26
6.Earnings quality & cash
VND bn168Q2/26
7.Asset structure
VND bn729Q2/26
8.Funding & debt health
VND bn · times729Q2/26
9.Revenue backlog
VND bn4,16Q2/26
10.Valuation
times · %5,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %2.335Q2/26
Adjusted EPS growth, latest quarter
45.6%
Average adjusted EPS growth, 3 quarters
117%
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26